Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT03533751 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: Etokimab
DRUG: Placebo

Sponsor

AnaptysBio, Inc.